On September 10, 2025, the final rule to implement the Cybersecurity Maturity Model Certification (“CMMC”) program in the Defense Federal Acquisition Regulation Supplement (“DFARS”) was published with ...

On September 8, 2025, the Nasdaq Stock Market submitted a proposed rule change to the Securities and Exchange Commission that, if implemented, would allow for the trading and settlement of tokenized ...

On Friday, September 5, 2025, the Federal Trade Commission (FTC or the Commission) brought its multiyear effort to ban employee noncompete agreements to a conclusion.

Background On September 4, 2025, the Washington Supreme Court issued its decision in Branson v. Washington Fine Wine & Spirits LLC. The case centered on how the term “job applicant” should be ...

As US pharmaceutical manufacturers continue to lead biopharmaceutical research and development, they find themselves increasingly at odds with the nation’s shifting regulatory landscape — a reality ...

As we wrote in May, the Third Circuit handed down the first appellate decision on the merits of manufacturers’ claims. In affirming the trial court and rejecting claims by AstraZeneca that the ...

Examinations under oath (EUOs) are a common coverage condition in property and other first-party insurance policies that can make or break an insurance claim. In theory, EUOs are straightforward: they ...

There is a widely-reported trend of companies reincorporating out of Delaware into states like Texas, Nevada, and Florida due to recent Delawar ...

On April 24, 2025, the Senate Health, Education, Labor & Pensions (HELP) Committee, led by Sen. Bill Cassidy (R-La.), released a report on its investigation into the 340B program.

On July 17, 2025, the U.S. District Court for the Central District of California issued a ruling in Sivakova v. American Honda Motor Co., addressing whether plaintiffs had adequately pleaded a claim ...

The U.S. Food and Drug Administration (“FDA”) announced the launch of its “Green List” initiative designed to protect consumers from illegally imported GLP-1 drug ingredients—such as semaglutide and ...

The Supreme Court issued a fractured, 4-1-4 ruling on its emergency docket in National Institutes of Health v. American Public Health Association, No. 25A103, 606 U.S. ____ (2025) (per curiam) (“NIH”) ...